KR20250073200A - 영상화 및 표적화된 방사선요법을 위한 신규한 미니가스트린-유래된 콜레시스토키닌 2 수용체 결합 분자 - Google Patents
영상화 및 표적화된 방사선요법을 위한 신규한 미니가스트린-유래된 콜레시스토키닌 2 수용체 결합 분자 Download PDFInfo
- Publication number
- KR20250073200A KR20250073200A KR1020257012384A KR20257012384A KR20250073200A KR 20250073200 A KR20250073200 A KR 20250073200A KR 1020257012384 A KR1020257012384 A KR 1020257012384A KR 20257012384 A KR20257012384 A KR 20257012384A KR 20250073200 A KR20250073200 A KR 20250073200A
- Authority
- KR
- South Korea
- Prior art keywords
- dota
- glu
- sifa
- cck
- trp
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1024—Tetrapeptides with the first amino acid being heterocyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/06—Macromolecular compounds, carriers being organic macromolecular compounds, i.e. organic oligomeric, polymeric, dendrimeric molecules
- A61K51/065—Macromolecular compounds, carriers being organic macromolecular compounds, i.e. organic oligomeric, polymeric, dendrimeric molecules conjugates with carriers being macromolecules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Pharmacology & Pharmacy (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP22196630 | 2022-09-20 | ||
| EP22196630.2 | 2022-09-20 | ||
| PCT/EP2023/063469 WO2024061483A1 (en) | 2022-09-20 | 2023-05-19 | Novel minigastrin-derived cholecystokinin 2 receptor binding molecules for imaging and targeted radiotherapy |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR20250073200A true KR20250073200A (ko) | 2025-05-27 |
Family
ID=83994946
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020257012384A Pending KR20250073200A (ko) | 2022-09-20 | 2023-05-19 | 영상화 및 표적화된 방사선요법을 위한 신규한 미니가스트린-유래된 콜레시스토키닌 2 수용체 결합 분자 |
Country Status (9)
| Country | Link |
|---|---|
| EP (2) | EP4590347A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2025532619A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20250073200A (cg-RX-API-DMAC7.html) |
| CN (1) | CN119907695A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2023345654A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3264385A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL319379A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2025003151A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2024061483A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12642876B1 (en) | 2025-10-30 | 2026-06-02 | Perspective Therapeutics, Inc. | Cholecystokinin-2 receptor targeted compounds and use thereof |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3412303A1 (en) * | 2017-06-08 | 2018-12-12 | Medizinische Universität Innsbruck | Improved pharmacokinetics and cholecystokinin-2 receptor (cck2r) targeting for diagnosis and therapy |
| KR20240027896A (ko) * | 2017-07-28 | 2024-03-04 | 테크니쉐 우니베르지테트 뮌헨 | 이중 모드 방사성 트레이서 및 치료법 |
| EP4023250A1 (en) * | 2021-01-04 | 2022-07-06 | Technische Universität München | Dual mode radiotracer and -therapeutics |
-
2023
- 2023-05-19 CA CA3264385A patent/CA3264385A1/en active Pending
- 2023-05-19 IL IL319379A patent/IL319379A/en unknown
- 2023-05-19 EP EP23727562.3A patent/EP4590347A1/en active Pending
- 2023-05-19 WO PCT/EP2023/063469 patent/WO2024061483A1/en not_active Ceased
- 2023-05-19 JP JP2025515980A patent/JP2025532619A/ja active Pending
- 2023-05-19 AU AU2023345654A patent/AU2023345654A1/en active Pending
- 2023-05-19 KR KR1020257012384A patent/KR20250073200A/ko active Pending
- 2023-05-19 EP EP25193071.5A patent/EP4631959A3/en active Pending
- 2023-05-19 CN CN202380067423.2A patent/CN119907695A/zh active Pending
-
2025
- 2025-03-18 MX MX2025003151A patent/MX2025003151A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA3264385A1 (en) | 2024-03-28 |
| CN119907695A (zh) | 2025-04-29 |
| JP2025532619A (ja) | 2025-10-01 |
| AU2023345654A1 (en) | 2025-02-27 |
| WO2024061483A1 (en) | 2024-03-28 |
| MX2025003151A (es) | 2025-04-02 |
| EP4590347A1 (en) | 2025-07-30 |
| IL319379A (en) | 2025-05-01 |
| EP4631959A3 (en) | 2025-12-17 |
| EP4631959A2 (en) | 2025-10-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7572080B2 (ja) | 画像化および内部放射線療法のためのpsmaリガンド | |
| CN111132700B (zh) | 双模放射性示踪剂与治疗剂 | |
| JP2026031934A (ja) | 安定した濃縮放射性医薬組成物 | |
| JP2024123022A (ja) | ガストリン放出ペプチド受容体(grpr)のインビボイメージングおよびgrpr関連障害の治療のための放射性標識ボンベシン由来化合物 | |
| JP7838149B2 (ja) | 癌のイメージングおよび治療のための修飾されたgrprアンタゴニストペプチド | |
| AU2022219294A9 (en) | Cxcr4-ligands for diagnostic and therapeutic use and precursors thereof | |
| EP4631959A2 (en) | Novel minigastrin-derived cholecystokinin 2 receptor binding molecules for imaging and targeted radiotherapy | |
| US20250313579A1 (en) | Ligand compounds comprising a chelating group as a bridging group | |
| JP2024517971A (ja) | 放射性医薬品のソマトスタチン受容体リガンドおよびその前駆体 | |
| JP2025525111A (ja) | 放射性医薬品のためのケイ素系フッ化物アクセプター基 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0105 | International application |
St.27 status event code: A-0-1-A10-A15-nap-PA0105 |
|
| PG1501 | Laying open of application |
St.27 status event code: A-1-1-Q10-Q12-nap-PG1501 |
|
| P11 | Amendment of application requested |
Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-NAP-X000 (AS PROVIDED BY THE NATIONAL OFFICE) |
|
| P11-X000 | Amendment of application requested |
St.27 status event code: A-2-2-P10-P11-nap-X000 |